Search Results - "Joy, Anil"

Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents by Wang, Richard C, Chen, Xinmei, Parissenti, Amadeo M, Joy, Anil A, Tuszynski, Jack, Brindley, David N, Wang, Zhixiang

“…One of the main reasons for disease recurrence in the curative breast cancer treatment setting is the development of drug resistance. Microtubule targeted…”
Get full text

Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy by Virani, Sean A., MD, MSc, MPH, FRCPC, Brezden-Masley, Christine, MD, PhD, FRCPC, Clarke, Brian, MD, FRCPC, FACC, Davis, Margot K., MD, FRCPC, Jassal, Davinder S., MD, FACC, FRCP(C), Johnson, Christopher, MD, FRCPC, Lemieux, Julie, MD, MSc, FRCPC, Paterson, Ian, MD, FRCPC, Sebag, Igal A., MD, FRCPC, FACC, FASE, Simmons, Christine, MD, MSc, FRCPC, Sulpher, Jeffrey, MD, FRCPC, Thain, Kishore, MD, FRCPC, Thavendiranathan, Paaldinesh, MD, MSc, FRCPC, Wentzell, Jason R., BScPharm, ACPR, Wurtele, Nola, MN, NP(A), Dent, Susan, MD, FRCPC, Côté, Marc André, MD, FRCPC, Fine, Nowell M., MD, MS, FRCPC, Haddad, Haissam, MD, FRCPC, FACC, Hayley, Bradley D., MD, FRCPC, Hopkins, Sean, B.Sc.(Hon), BSP, Joy, Anil A., MD, Rayson, Daniel, MD, FRCPC, FACP, Stadnick, Ellamae, MD, MSc, FRCPC, Straatman, Lynn, MD, FRCPC

“…Abstract Modern treatment strategies have led to improvements in cancer survival, however these gains may be offset by the potential negative impact of cancer…”
Get full text

Evaluating Survivorship Care Plans: Results of a Randomized, Clinical Trial of Patients With Breast Cancer by GRUNFELD, Eva, JULIAN, Jim A, PORTER, Geoffrey A, PASZAT, Lawrence F, PRITCHARD, Kathleen I, ROBIDOUX, Andre, SMITH, Sally, SUSSMAN, Jonathan, DENT, Susan, SISLER, Jeffrey, WIERNIKOWSKI, Jennifer, LEVINE, Mark N, POND, Gregory, MAUNSELL, Elizabeth, COYLE, Douglas, FOLKES, Amy, JOY, Anil A, PROVENCHER, Louise, RAYSON, Daniel, RHEAUME, Dorianne E

“…An Institute of Medicine report recommends that patients with cancer receive a survivorship care plan (SCP). The trial objective was to determine if an SCP for…”
Get full text

Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations by Jones, Lee W, Dr, Eves, Neil D, PhD, Haykowsky, Mark, Prof, Joy, Anil A, MD, Douglas, Pamela S, Prof

“…Summary The use of exercise testing as an objective assessment of cardiorespiratory fitness in clinical oncology research has increased substantially over the…”
Get full text

Palbociclib plus endocrine therapy in older women with HR+/HER2– advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies by Rugo, Hope S., Turner, Nicholas C., Finn, Richard S., Joy, Anil A., Verma, Sunil, Harbeck, Nadia, Masuda, Norikazu, Im, Seock-Ah, Huang, Xin, Kim, Sindy, Sun, Wan, Iyer, Shrividya, Schnell, Patrick, Bartlett, Cynthia Huang, Johnston, Stephen

“…Because incidence of breast cancer and comorbidities increase with age, it is important to determine treatment benefit in elderly patients. We evaluated…”
Get full text

Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review by Robinson, Andrew, Souied, Osama, Bota, A. Brianne, Levasseur, Nathalie, Stober, Carol, Hilton, John, Kamel, Dalia, Hutton, Brian, Vandermeer, Lisa, Mazzarello, Sasha, Joy, Anil A., Fergusson, Dean, McDiarmid, Sheryl, McInnes, Mathew, Shorr, Risa, Clemons, Mark

“…Importance Systemic chemotherapy can be administered either through a peripheral vein (IV), or centrally through peripherally inserted central catheter (PICC),…”
Get full text

Rationale and design of the Diet Restriction and Exercise-induced Adaptations in Metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, calorie-restricted, and ketogenic diet plus exercise during intravenous chemotherapy versus usual care by Kirkham, Amy A, King, Karen, Joy, Anil A, Pelletier, André B, Mackey, John R, Young, Kelvin, Zhu, Xiaofu, Meza-Junco, Judith, Basi, Sanraj K, Hiller, Julie Price, Brkin, Tina, Michalowski, Bonnie, Pituskin, Edith, Paterson, D Ian, Courneya, Kerry S, Thompson, Richard B, Prado, Carla M

“…An underlying cause of solid tumor resistance to chemotherapy treatment is diminished tumor blood supply, which leads to a hypoxic microenvironment, dependence…”
Get full text

Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2 by Gelmon, Karen, Walshe, Janice M., Mahtani, Reshma, Joy, Anil A., Karuturi, Meghan, Neven, Patrick, Lu, Dongrui Ray, Kim, Sindy, Schnell, Patrick, Bananis, Eustratios, Schwartzberg, Lee

“…In the PALOMA-2 trial, palbociclib in combination with letrozole prolonged progression-free survival (PFS) and exhibited an acceptable safety profile in…”
Get full text

Evaluating predictive equations for energy requirements throughout breast cancer trajectory: A comparative study by da Silva, Bruna R., Pagano, Ana Paula, Kirkham, Amy A., Gonzalez, Maria Cristina, Haykowsky, Mark J., Joy, Anil A., King, Karen, Singer, Pierre, Cereda, Emanuele, Paterson, Ian, Pituskin, Edith, Thompson, Richard, Prado, Carla M.

“…Accurately estimating resting energy requirements is crucial for optimizing energy intake, particularly in the context of patients with varying energy needs,…”
Get full text

Unwarranted imaging for distant metastases in patients with newly diagnosed ductal carcinoma in situ and stage I and II breast cancer by Lupichuk, Sasha, Tilley, Derek, Surgeoner, Brae, King, Karen, Joy, Anil Abraham

“…In 2012, the American Society of Clinical Oncology (ASCO) released a Choosing Wisely Top Five list that included a recommendation against ordering advanced…”
Get full text

Implementation of weekday time‐restricted eating to improve metabolic health in breast cancer survivors with overweight/obesity by Kirkham, Amy A., Ford, Katherine L., Ramos Da Silva, Bruna, Topolnyski, Jordan, Prado, Carla M., Joy, Anil A., Paterson, D. Ian, Boulé, Normand, Pituskin, Edith, Haykowsky, Mark J., Thompson, Richard B.

“…Objective This study aimed to evaluate the implementation of telephone‐based delivery of weekday‐only time‐restricted eating (TRE), its preliminary efficacy…”
Get full text

Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions by Jones, Lee W., Peddle, Carolyn J., Eves, Neil D., Haykowsky, Mark J., Courneya, Kerry S., Mackey, John R., Joy, Anil A., Kumar, Vikaash, Winton, Timothy W., Reiman, Tony

“…BACKGROUND. To determine the effects of preoperative exercise training on cardiorespiratory fitness in patients undergoing thoracic surgery for malignant lung…”
Get full text

Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines by Simmons, Christine, Rayson, Daniel, Joy, Anil Abraham, Henning, Jan-Willem, Lemieux, Julie, McArthur, Heather, Card, Paul B., Dent, Rebecca, Brezden-Masley, Christine

“…Background: Evidence to date supports continued human epidermal growth factor receptor 2 (HER2) suppression beyond progression on HER2-directed therapy for…”
Get full text

Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer by Mita, Monica M, Joy, Anil A, Mita, Alain, Sankhala, Kamalesh, Jou, Ying-Ming, Zhang, Da, Statkevich, Paul, Zhu, Yali, Yao, Siu-Long, Small, Karen, Bannerji, Rajat, Shapiro, Charles L

“…Micro-Abstract This study assessed the efficacy and safety of dinaciclib, a cyclin-dependent kinase inhibitor, compared with capecitabine in patients with…”
Get full text

Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast Cancer by RUGO, Hope S, STOPECK, Alison T, BAIR, Angel H, SOULIERES, Denis, JOY, Anil A, CHAN, Stephen, VERMA, Shailendra, LLUCH, Anna, LIAU, Katherine F, KIM, Sinil, BYCOTT, Paul, ROSBROOK, Brad

“…This multicenter, randomized, double-blind, phase II study assessed safety and efficacy of axitinib plus docetaxel in metastatic breast cancer (MBC). Women…”
Get full text

CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC by Leighl, Natasha B, Laurie, Scott A, Goss, Glenwood D, Hughes, Brett G M, Stockler, Martin, Tsao, Ming-Sound, Hwang, David M, Joubert, Phillipe, Kulkarni, Swati, Blais, Normand, Joy, Anil A, Mates, Mihaela, Rana, Punam, Yadav, Sunil K, Underhill, Craig, Lee, Christopher, Bradbury, Penelope A, Hiltz, Andrea, Dancey, Janet, Ding, Keyue, Vera-Badillo, Francisco

“…First-line therapy for patients with metastatic NSCLC includes checkpoint inhibitor monotherapy, dual checkpoint inhibition, or combination with chemotherapy…”
Get more information

Time-Restricted Eating in Breast Cancer Survivors: Effects on Body Composition and Nutritional Status by Da Silva, Bruna Ramos, Kirkham, Amy A, Ford, Katherine L, Haykowsky, Mark J, Paterson, D Ian, Joy, Anil A, Pituskin, Edith, Thompson, Richard, Prado, Carla M

“…In this secondary analysis of an 8-wk single-arm feasibility study of weekday time-restricted eating (TRE), we explored the effects of TRE on body composition…”
Get full text

Gastric adenocarcinoma: Review and considerations for future directions by DICKEN, Bryan J, BIGAM, David L, CASS, Carol, MACKEY, John R, JOY, Anil A, HAMILTON, Stewart M

“…This update reviews the epidemiology and surgical management, and the controversies of gastric adenocarcinoma. We provide the relevance of outcome data to…”
Get full text

Virtual or In-Person: A Mixed Methods Survey to Determine Exercise Programming Preferences during COVID-19 by Suderman, Kirsten, Skene, Tara, Sellar, Christopher, Dolgoy, Naomi, Pituskin, Edith, Joy, Anil A, Culos-Reed, Susan Nicole, McNeely, Margaret L

“…A survey was conducted to identify barriers and facilitators to engaging in virtual and in-person cancer-specific exercise during COVID-19. A theory-informed,…”
Get full text

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain by Rayson, Daniel, Gandhi, Sonal, Joy, Anil A, Brezden-Masley, Christine, Gelmon, Karen A, Sehdev, Sandeep, Cescon, David, Chia, Stephen

“…The addition of pertuzumab to neoadjuvant trastuzumab and chemotherapy for women with early-stage, high-risk, HER2+ breast cancer has been observed to lead to…”
Get full text